3DBio Holdings LLC is a clinical-stage biotechnology company based in Brooklyn, NY, specializing in regenerative medicine. They are at the forefront of developing and implanting 3D-bioprinted living tissues in patients, offering custom-engineered solutions to medical challenges.
With their innovative four-part technology platform, including a novel 3D-bioprinter, bio-ink, specialized cell culture system, and implantable protective shell, 3DBio pioneers the development of living tissue implants with both structural and functional integrity. Their groundbreaking work is currently being evaluated in a clinical trial for their patient-matched, patient tissue-derived product, AuriNovo, in both adults and children.
Generated from the website